Caprico Biotechnologies Inc exhibiting at the 2017 American Society of Hematology (ASH) Conference in booth 2653.
Norcoss, Georgia (November 28, 2017)
Caprico Biotechnologies Inc (CBI) today announced that it will be exhibiting in booth 2653 at the 2017 American Society of Hematology (ASH) conference to be held in Atlanta, GA from December 9-11.
Products and services that CBI will be highlighting include:
· Custom Engineered Monoclonal Antibody Services.
· Antibodies for Neutrophils, Eosinophils, Basophils, Monocytes, T Cell, B Cells, NK Cells, and Macrophages.
· Immunophenotyping Reagents for Flow Cytometry, Immunohistochemistry, and Western Blot.
“The ASH conference is the premier hematology meeting of the year and CBI’s attendance provides an ideal opportunity to highlight the solutions that we can provide to researchers and clinicians working in the immunophenotyping and immuno-monitoring fields” said Dr Remus Li, MD, President and CEO. Dr Li added “CBI already provides over 500 different purified and labeled antibody combinations in addition to custom antibody production and we continue to expand our portfolio to ensure that high quality cost effective products are available.”
For more information, contact:
Punya Mardhanan: Director of Marketing & Sales
Telephone +1 678-691-2143 ext 101
Caprico Biotechnologies Inc (CBI) is a provider of products and services with flow cytometry applications in an ISO9001 / ISO 13485 compliant facility. Core business activities include the production and supply of purified and labeled monoclonal antibodies for immunephenotyping and immunemonitoring and custom hybridoma development and labeling services. For more information about CBI visit their website at www.capricobio.com
Copyright © 2017 Caprico Biotechnologies Inc, All rights reserved